Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stanley C Jordan

Showing results (101-110 of 191) with videos related to

Pageof 20
Sort By:
Journal of Clinical Apheresis|August 7, 2009
Therapeutic plasma exchange for desensitization prior to transplantation in ABO-incompatible renal allograftsPraveen Sivakumaran, Ashley A Vo, Rafael Villicana, et al.
Transplant Immunology|December 3, 2014
Genes associated with antibody-dependent cell activation are overexpressed in renal biopsies from patients with antibody-mediated rejectionElina Suviolahti, Shili Ge, Cynthia C Nast, et al.
Transplantation|September 25, 2008
Acceptable donor-specific antibody levels allowing for successful deceased and living donor kidney transplantation after desensitization therapyNancy L Reinsmoen, Chih-Hung Lai, Ashley Vo, et al.
Transplant Immunology|July 25, 2006
Adenovirus mediated IL-10 gene transfer to the airway of the rat lung for prevention of lung allograft rejectionYoshinori Okada, Xiao-Jing Zuo, Mieko Toyoda, et al.
Transplantation|April 3, 2020
Interleukin-6: An Important Mediator of Allograft InjuryStanley C Jordan, Noriko Ammerman, Jua Choi, et al.
Clinical Journal of the American Society of Nephrology : CJASN|October 17, 2009
Acute hemolysis after high-dose intravenous immunoglobulin therapy in highly HLA sensitized patientsJoseph Kahwaji, Eva Barker, Sam Pepkowitz, et al.
Transplantation|March 21, 2013
Efficacy, outcomes, and cost-effectiveness of desensitization using IVIG and rituximabAshley A Vo, Jeffrey Petrozzino, Kai Yeung, et al.
Transplantation|January 22, 2015
Factors Predicting Risk for Antibody-mediated Rejection and Graft Loss in Highly Human Leukocyte Antigen Sensitized Patients Transplanted After DesensitizationAshley A Vo, Aditi Sinha, Mark Haas, et al.
Pediatric Transplantation|March 27, 2022
Use of a donor-derived cell-free DNA assay to monitor treatment response in pediatric renal transplant recipients with allograft rejectionJustin A Steggerda, Helen Pizzo, Jonathan Garrison, et al.
Clinical Journal of the American Society of Nephrology : CJASN|August 21, 2007
Safety and adverse events profiles of intravenous gammaglobulin products used for immunomodulation: a single-center experienceAshley A Vo, Vinh Cam, Mieko Toyoda, et al.
Pageof 20

Showing results (101-110 of 191) with videos related to

Sort By:
Pageof 20
Journal of Clinical Apheresis|August 7, 2009
Therapeutic plasma exchange for desensitization prior to transplantation in ABO-incompatible renal allograftsPraveen Sivakumaran, Ashley A Vo, Rafael Villicana, et al.
Transplant Immunology|December 3, 2014
Genes associated with antibody-dependent cell activation are overexpressed in renal biopsies from patients with antibody-mediated rejectionElina Suviolahti, Shili Ge, Cynthia C Nast, et al.
Transplantation|September 25, 2008
Acceptable donor-specific antibody levels allowing for successful deceased and living donor kidney transplantation after desensitization therapyNancy L Reinsmoen, Chih-Hung Lai, Ashley Vo, et al.
Transplant Immunology|July 25, 2006
Adenovirus mediated IL-10 gene transfer to the airway of the rat lung for prevention of lung allograft rejectionYoshinori Okada, Xiao-Jing Zuo, Mieko Toyoda, et al.
Transplantation|April 3, 2020
Interleukin-6: An Important Mediator of Allograft InjuryStanley C Jordan, Noriko Ammerman, Jua Choi, et al.
Clinical Journal of the American Society of Nephrology : CJASN|October 17, 2009
Acute hemolysis after high-dose intravenous immunoglobulin therapy in highly HLA sensitized patientsJoseph Kahwaji, Eva Barker, Sam Pepkowitz, et al.
Transplantation|March 21, 2013
Efficacy, outcomes, and cost-effectiveness of desensitization using IVIG and rituximabAshley A Vo, Jeffrey Petrozzino, Kai Yeung, et al.
Transplantation|January 22, 2015
Factors Predicting Risk for Antibody-mediated Rejection and Graft Loss in Highly Human Leukocyte Antigen Sensitized Patients Transplanted After DesensitizationAshley A Vo, Aditi Sinha, Mark Haas, et al.
Pediatric Transplantation|March 27, 2022
Use of a donor-derived cell-free DNA assay to monitor treatment response in pediatric renal transplant recipients with allograft rejectionJustin A Steggerda, Helen Pizzo, Jonathan Garrison, et al.
Clinical Journal of the American Society of Nephrology : CJASN|August 21, 2007
Safety and adverse events profiles of intravenous gammaglobulin products used for immunomodulation: a single-center experienceAshley A Vo, Vinh Cam, Mieko Toyoda, et al.
Pageof 20